Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with Diabetes.
COVID-19
Diabetes
Health care workers
Remote continuous glucose monitoring
SARS-CoV-2
Journal
Diabetes technology & therapeutics
ISSN: 1557-8593
Titre abrégé: Diabetes Technol Ther
Pays: United States
ID NLM: 100889084
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
9
7
2020
medline:
14
1
2021
entrez:
9
7
2020
Statut:
ppublish
Résumé
Diabetes is associated with mortality and severity of coronavirus disease (COVID-19). Protecting against infection in health care workers at high risk of COVID-19 is critical. This report investigates the usefulness and safety of remote continuous glucose monitoring (CGM) in a patient with diabetes and severe interstitial pneumonia caused by the coronavirus disease. The Dexcom G4 Platinum CGM system
Identifiants
pubmed: 32639844
doi: 10.1089/dia.2020.0237
doi:
Substances chimiques
Blood Glucose
0
Insulin
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM